Alembic Pharma Q3 Results Review - India, Export Formulation Drive Earnings: Motilal Oswal
2 months ago•Bloomberg Quint
Alembic, Aurobindo recall drugs in US market
7 months ago•Economic Times
Alembic aims for US rebound with new launches
8 months ago•Economic Times
Reduce Alembic Pharma; target of Rs 705: ICICI Securities
8 months ago•Moneycontrol
Broker’s call: Alembic Pharma (Buy)
8 months ago•The Hindu Businessline
Alembic Pharma Q1 Results Review - Execution Remains A Key: Dolat Capital
8 months ago•Bloomberg Quint
Stock to buy today: Alembic Pharmaceuticals (₹732.15)
8 months ago•The Hindu Businessline